#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Dementia Alzheimer's type Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Stiff person syndrome Chemical burn Hereditary angioedema with C1 esterase inhibitor deficiency Juvenile idiopathic arthritis Congenital absence of bile ducts Alveolar rhabdomyosarcoma Richter's syndrome Acute graft versus host disease in liver Kawasaki's disease B-cell small lymphocytic lymphoma recurrent T-cell type acute leukaemia Cholestatic pruritus Myelin oligodendrocyte glycoprotein antibody-associated disease Chronic inflammatory demyelinating polyradiculoneuropathy Proteus syndrome More trials…

    Learn about Rare Diseases

    Congenital nephrogenic diabetes insipidus – Diagnostics Gaucher’s disease type I Pleomorphic leiomyosarcoma Angelman’s syndrome Niemann-Pick disease – Trials in Disease Waldenstrom’s macroglobulinaemia recurrent – Life with Disease Arterial tortuosity syndrome Methylmalonic acidaemia Niemann-Pick disease – Life with Disease Leiomyosarcoma recurrent More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Digitoxin Aup1602-C Methylprednisolone Brimonidine Tartrate Amikacin Infliximab Peppermint Oil Avapritinib TRIACYLGLYCEROL LIPASE Leniolisib Phosphate Arachis Hypogaea (762) Sabatolimab Human Albumin Solution Omaveloxolone Tianeptine Sodium Asciminib Sodium Iodide (131I) Mesenchymal Cells Rifamycin Sodium Citicoline Sodium More therapies…

    Learn about Your Condition

    Castleman's disease Fallopian tube cancer stage IV Adenocarcinoma pancreas Ligament sprain Abortion threatened Immunodeficiency congenital Nasal sinus cancer Complicated appendicitis Adenomatous polyposis coli Stress Pyelonephritis Cardiac failure chronic Carotid arteriosclerosis Small intestine leiomyosarcoma Pain More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Hormone-refractory prostate cancer

  • Study Comparing Docetaxel and Androgen Receptor-Targeted Agents (Abiraterone or Enzalutamide) for Patients with Metastatic Castration-Resistant Prostate Cancer

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Hormone-refractory prostate cancer
    Investigated Drugs:
    • Abiraterone
    • Docetaxel
    • Enzalutamide
    Italy

  • Study of Ebastine and Docetaxel for Treating Metastatic Castration-Resistant Prostate Cancer in Patients with Advanced Disease

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Hormone-refractory prostate cancer
    Investigated Drugs:
    • Ebastine
    • Cabazitaxel
    • Docetaxel
    Denmark

  • Study of Opevesostat, Olaparib, and Cabazitaxel in Patients with Advanced Prostate Cancer

    Recruiting

    1 1 1 1
    Investigated Diseases:
    • Hormone-refractory prostate cancer
    • Prostate cancer
    Investigated Drugs:
    • Drugs For Peptic Ulcer And Gastro-Oesophageal Reflux Disease (Gord)
    • Fludrocortisone Acetate
    • Hydrocortisone Acetate
    Denmark Finland France Germany Ireland Italy +2

  • Study on the Safety and Effects of Lutetium (177Lu) Vipivotide Tetraxetan in Adults with Metastatic Castration-Resistant Prostate Cancer

    Recruiting

    1 1 1 1
    Investigated Diseases:
    • Hormone-refractory prostate cancer
    Investigated Drugs:
    • Lutetium (177Lu) Vipivotide Tetraxetan
    • Gozetotide
    Germany The Netherlands Spain

  • Study Comparing MK-5684 with Abiraterone Acetate or Enzalutamide for Patients with Advanced Prostate Cancer After Hormonal Therapy and Chemotherapy

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Hormone-refractory prostate cancer
    Investigated Drugs:
    • Fludrocortisone Acetate
    • Opevesostat Tosilate
    • Prednisone Acetate
    Austria Czechia Denmark Finland France Germany +8

  • Study Comparing MK-5684 with Abiraterone Acetate or Enzalutamide for Patients with Advanced Prostate Cancer After Hormonal Therapy

    Recruiting

    3 1 1 1
    Investigated Drugs:
    • Fludrocortisone Acetate
    • Opevesostat Tosilate
    • Prednisone Acetate
    Czechia Estonia France Germany Greece Hungary +9
Previous Page
1 2 3 4 5 … 10
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!